Abstract
Coprolalia has been a recognized symptom of Tourette syndrome from the first description of the syndrome. Copropraxia is seen less frequently and almost always occurs in association with coprolalia. Prevalence of coprolalia varies from 8% in primary pediatric practices to over 60% in tertiary referral centers. Coprolalia tends to peak in severity during adolescence and to wane during adulthood. The pathogenesis may be related to dysfunction of basal ganglionic and limbic mini-circuits. Coprolalia has also been seen in a variety of other neurologic disorders. Treatment is primarily pharmacologic with dopamine-blocking agents.
| Original language | English |
|---|---|
| Pages (from-to) | 299-308 |
| Number of pages | 10 |
| Journal | Neurologic Clinics |
| Volume | 15 |
| Issue number | 2 |
| State | Published - Jan 1 1997 |
Fingerprint
ASJC Scopus subject areas
- Clinical Neurology
Cite this
Coprolalia and other coprophenomena. / Singer, Carlos.
In: Neurologic Clinics, Vol. 15, No. 2, 01.01.1997, p. 299-308.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Coprolalia and other coprophenomena
AU - Singer, Carlos
PY - 1997/1/1
Y1 - 1997/1/1
N2 - Coprolalia has been a recognized symptom of Tourette syndrome from the first description of the syndrome. Copropraxia is seen less frequently and almost always occurs in association with coprolalia. Prevalence of coprolalia varies from 8% in primary pediatric practices to over 60% in tertiary referral centers. Coprolalia tends to peak in severity during adolescence and to wane during adulthood. The pathogenesis may be related to dysfunction of basal ganglionic and limbic mini-circuits. Coprolalia has also been seen in a variety of other neurologic disorders. Treatment is primarily pharmacologic with dopamine-blocking agents.
AB - Coprolalia has been a recognized symptom of Tourette syndrome from the first description of the syndrome. Copropraxia is seen less frequently and almost always occurs in association with coprolalia. Prevalence of coprolalia varies from 8% in primary pediatric practices to over 60% in tertiary referral centers. Coprolalia tends to peak in severity during adolescence and to wane during adulthood. The pathogenesis may be related to dysfunction of basal ganglionic and limbic mini-circuits. Coprolalia has also been seen in a variety of other neurologic disorders. Treatment is primarily pharmacologic with dopamine-blocking agents.
UR - http://www.scopus.com/inward/record.url?scp=0031132914&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0031132914&partnerID=8YFLogxK
M3 - Article
C2 - 9115463
AN - SCOPUS:0031132914
VL - 15
SP - 299
EP - 308
JO - Neurologic Clinics
JF - Neurologic Clinics
SN - 0733-8619
IS - 2
ER -